ADA, OHA ask NCAA to pull cigar ads from bowl game
The ADA and Oral Health America (OHA) are among 10 major public health groups calling on the Orange Bowl Committee and the NCAA to cancel
The ADA and Oral Health America (OHA) are among 10 major public health groups calling on the Orange Bowl Committee and the NCAA to cancel
Combining Avastin (bevacizumab) with standard chemotherapy and radiation is safe and could extend the lives of people living with advanced nasopharyngeal cancer, according to a
When Sherry Wittenberg was diagnosed with a rare cancer in the cricoid cartilage of her larynx, doctors told her the only way to treat the
Multispectral imaging has long been used for space-based analysis of environmental conditions, crop management, and urban growth. Can this same advanced technology improve the ability
Survival rates among U.S. patients with cancer of the tonsils and base of the tongue have improved dramatically in the last 20 years, according to
DentalEZ Group has updated its Identafi website to include a section that provides marketing tools to help clinicians increase oral cancer awareness and promote the
Magnetic resonance imaging (MRI) could play an important role in the diagnosis of oral cancer, according to a study in Brazilian Oral Researcher (December 2011,
NEW YORK (Reuters Health) – A single session of photodynamic therapy using 5-aminolevulinic acid (5-ALA) and a pulsed dye laser shrank oral leukoplakia (OL) lesions
OralDNA Labs has enhanced its MyPerioPath patient lab report with the addition of an expanded section called MyPerioProgress. The MyPerioPath salivary diagnostic test identifies the
Using a combination of amoxicillin and metronidazole in conjunction with full-mouth scaling and root planing during the treatment of generalized, aggressive periodontitis is safe and
A-dec is now offering Cavitron ultrasonic scalers from Dentsply as a factory-installed option with the A-dec 300 or A-dec 500 delivery systems. With this option,
NephRx has gained rights to a U.S. patent related to the company’s novel peptide NX002, which is being developed for the treatment of oral mucositis